Hot of the Press: Lopinavir–Ritonavir NOT Effective in Severe COVID19 NEJM
Dr. Baliga's 'Got Knowledge Doc?' PODKASTS
Release Date: 03/18/2020
Dr. Baliga's 'Got Knowledge Doc?' PODKASTS
Summary on Kaṇāda Kaṇāda, also known as Ulūka or Kashyapa, was an ancient Indian natural philosopher and the founder of the Vaisheshika school of Indian philosophy. He is often regarded as the earliest proponent of atomism in the world, proposing that the universe is composed of indivisible, eternal atoms (paramanu), which combine in various ways to form different substances. His ideas were recorded in the seminal text Vaiśeṣika Sūtra, which outlined a realistic and pluralistic ontology. Estimated to have lived between the 6th century BCE and 2nd century BCE,...
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
The study investigates the K210del mutation in genetic cardiomyopathy, which impairs myocardial contractility due to calcium discoordination in the troponin complex. Using a structure-based drug repurposing approach, researchers identified risedronate, an FDA-approved bisphosphonate, as a structural corrector that restores the calcium-binding domain’s normal configuration. Experiments with patient-derived iPSC cardiomyocytes and a mouse model demonstrated that risedronate normalized calcium sensitivity, improved contraction velocity, and restored left ventricular function. The findings...
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
Recent randomized trials, including EARLY TAVR, AVATAR, RECOVERY, and EVOLVED, suggest benefits of early aortic valve replacement (AVR) in asymptomatic severe aortic stenosis (AS). Early AVR reduces stroke, heart failure hospitalizations, and cardiovascular events, with a trend toward improved survival. The data support shifting from clinical surveillance to early intervention?
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
The EVOLVED trial investigated whether early aortic valve intervention could improve outcomes in asymptomatic patients with severe aortic stenosis and myocardial fibrosis. The randomized, multicenter study of 224 patients found no significant difference in all-cause mortality or unplanned aortic stenosis-related hospitalizations between early intervention and guideline-directed conservative management. However, early intervention was associated with lower rates of NYHA class II-IV symptoms and fewer unplanned hospitalizations. The trial highlights the potential symptomatic benefits of early...
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
Summary: Cold-Related Deaths in the US (1999–2022) 1. Overview and Trends • Cold-related deaths more than doubled over the study period. • 40,079 deaths recorded; age-adjusted mortality rate (AAMR) rose from 0.44 (1999) to 0.92 (2022) per 100,000 population (109% increase). • A significant upward trend began in 2017, with an annual percentage change (APC) of 12.1%. 2. Demographic Insights • Age: Mortality was highest among individuals aged ≥75 years (4.23/100,000 in 2022). • Largest Increase: Adults aged 45–74 years experienced the steepest rise (APC: 4.8%). • Gender: Males...
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
The AZALEA–TIMI 71 trial compared abelacimab, a monoclonal antibody targeting factor XI, with rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk. 🚨 New study: Abelacimab vs. Rivaroxaban in AFib 📊 ✅ 62-69% lower bleeding risk than rivaroxaban ✅ 5x lower GI bleeding ⚠️ Slightly higher ischemic stroke rates A promising safer anticoagulant? 🔬 More data needed! #CardioTwitter #CardioEd #MedEd Abelacimab significantly reduced bleeding compared to rivaroxaban (HR: 0.38 for 150 mg, 0.31 for 90 mg, p<0.001). Gastrointestinal bleeding was five times...
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
The Tri.Fr Randomized Clinical Trial evaluated the efficacy of Transcatheter Edge-to-Edge Repair (T-TEER) + Optimized Medical Therapy (OMT) versus OMT alone in 300 patients with severe, symptomatic tricuspid regurgitation (TR) across 24 centers in France and Belgium. At 1-year follow-up, 74.1% of patients in the T-TEER group improved, compared to 40.6% in the OMT-alone group (P < .001). T-TEER significantly reduced TR severity, improved NYHA class, patient global assessment (PGA), and Kansas City Cardiomyopathy Questionnaire (KCCQ) scores, and had a high procedural success rate (97.3%)...
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
Three studies examined the health impacts of aircraft noise exposure. The Heathrow Study (2023) found that nighttime aircraft noise increased cardiovascular events, particularly between 22:00–23:00 and 04:30–06:00, likely due to sleep disturbance and stress-related mechanisms. 🚨 New studies link aircraft noise to serious health risks! 🛩️🔊 📌 Nighttime noise boosts heart disease risk 🫀 📌 Increases cognitive decline & dementia risk 🧠 📌 Alters heart structure, raising cardiac event risk 💔 Time for stronger noise regulations! #Health...
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
🚨 Air traffic controllers face severe fatigue due to the 2-2-1 shift system, causing sleep loss, cognitive impairment & safety risks. 🛑 FAA & NATCA now plan to replace it with a safer schedule to enhance aviation safety. ✈️ #Fatigue #AviationSafety #ATC The 2-2-1 shift system in air traffic control (ATC) compresses five shifts into four days, leading to severe fatigue due to counterclockwise rotation and insufficient rest periods. The FAA’s 2024 study found that this schedule causes sleep deprivation, cognitive impairment, and increased safety risks, with 77% of...
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
The POPular PAUSE TAVI trial investigated whether continuing or interrupting oral anticoagulation during transcatheter aortic valve implantation (TAVI) affected clinical outcomes. The randomized, open-label, noninferiority study included 858 patients and assessed a composite primary outcome of cardiovascular death, stroke, myocardial infarction, major vascular complications, or major bleeding at 30 days. The trial found that continuation was not noninferior to interruption, with higher bleeding risk but no significant difference in thromboembolic events, supporting interruption of...
info_outlineHot of the Press: Lopinavir–Ritonavir NOT Effective in Severe COVID19 NEJM March 18, 2020
Dr RR Baliga's 'Got Knowledge Doc' Podcasts for Physicians
Not Medical Advice or Opinion